Alan Haruo Bryce, Raymond S. McDermott, Josep M. Piulats, M. Neil Reaume, Peter James Ostler, Joel Roger Gingerich, Elias Pintus, Srikala S. Sridhar, Richard Martin Bambury, Urban Emmenegger, Henriette Lindberg, David Morris, Franco Nole, John Nicholas Staffurth, Wassim Abida, Lisa Caunt, Darrin Despain, Charles J. Ryan, Karim Fizazi, Simon Chowdhury. "Rucaparib vs docetaxel (DTX) or second-generation androgen pathway inhibitor (ARPI) therapy for metastatic castration-resistant prostate cancer (mCRPC): TRITON3 final overall survival (OS) and safety.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.5_suppl.155